Assignee
BRITISH COLUMBIA CANCER AGENCY
CA·4 granted patents·13 pending applications·38 citations·filing 2006–2020
Top patents by PatentIndex Score
17 records- 0194US9365510B2Aziridine bisphenol ethers and related compounds and methods for their useBRITISH COLUMBIA CANCER AGENCY·Filed 2013·Granted Jun 14, 2016·16 cites·46 claims
- 0293US8686050B2Diglycidic ether derivative therapeutics and methods for their useBRITISH COLUMBIA CANCER AGENCY·Filed 2013·Granted Apr 1, 2014·19 cites·14 claims
- 0373US9045801B2Biomarkers for non-hodgkin lymphomas and uses thereofBRITISH COLUMBIA CANCER AGENCY·Filed 2013·Granted Jun 2, 2015·2 cites·3 claims
- 0462US10627411B2T-cell epitope identificationBRITISH COLUMBIA CANCER AGENCY·Filed 2015·Granted Apr 21, 2020·1 cites·8 claims
- 0553US2011195070A1Detection of granulosa-cell tumorsBRITISH COLUMBIA CANCER AGENCY·Filed 2009·Application pending·0 cites
- 0652US2015010469A1Bisphenol ether compounds with novel bridging groups and methods for their useBRITISH COLUMBIA CANCER AGENCY·Filed 2014·Application pending·0 cites
- 0751US2020241003A1T-cell epitope identificationBRITISH COLUMBIA CANCER AGENCY·Filed 2020·Application pending·0 cites
- 0850US2013195843A1Biomarkers for Non-Hodgkin Lymphomas and Uses ThereofBRITISH COLUMBIA CANCER AGENCY·Filed 2013·Application pending·0 cites
- 0949US2011224313A1Compositions and methods for classifying lung cancer and prognosing lung cancer survivalBRITISH COLUMBIA CANCER AGENCY·Filed 2009·Application pending·0 cites
- 1048US2013131488A1Multimodal detection of tissue abnormalities based on raman and background fluorescence spectroscopyBRITISH COLUMBIA CANCER AGENCY·Filed 2012·Application pending·0 cites
- 1147US2014303034A1Predicting prognosis in classic hodgkin lymphomaBRITISH COLUMBIA CANCER AGENCY·Filed 2012·Application pending·0 cites
- 1242US2009035318A1Method and composition for increasing the engraftment efficiency of stem cellsBRITISH COLUMBIA CANCER AGENCY·Filed 2006·Application pending·0 cites
- 1342US2009011456A1Methods for the Diagnosis and Prognosis of Graft Versus Host Disease By Measurement of Peripheral Cd3+Cd4+Cd8Beta+ CellsBRITISH COLUMBIA CANCER AGENCY·Filed 2007·Application pending·0 cites
- 1441US2015072021A1Methods and Kits for Predicting Outcome and Methods and Kits for Treating Breast Cancer with Radiation TherapyBRITISH COLUMBIA CANCER AGENCY·Filed 2014·Application pending·0 cites
- 1535US2016074674A1Combined respiration and cardiac gating for radiotherapy using electrical impedance technologyBRITISH COLUMBIA CANCER AGENCY·Filed 2014·Application pending·0 cites
- 1633US2014037620A1Methods of Treating Breast Cancer with Gemcitabine TherapyBRITISH COLUMBIA CANCER AGENCY·Filed 2013·Application pending·0 cites
- 1733US2014308241A1Biomarkers for t cell malignancies and uses thereofBRITISH COLUMBIA CANCER AGENCY·Filed 2012·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when BRITISH COLUMBIA CANCER AGENCY files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →